Nivolumab as a promising treatment option for metastatic salivary duct carcinoma

Salivary duct carcinomas (SDC) of the parotid gland are rarely occurring highly malignant tumors. A 65-year-old man presented with a preauricular mass. After surgical treatment and histologic examination, the findings were interpreted as a squamous cell carcinoma (SCC) metastasis of the parotid glan...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Bugia, Luis (VerfasserIn) , Jungbauer, Frederic (VerfasserIn) , Zaubitzer, Lena (VerfasserIn) , Hörner, Christian (VerfasserIn) , Merx, Kirsten (VerfasserIn) , Yasser, Abo-Madyan (VerfasserIn) , Germann, Thomas (VerfasserIn) , Lammert, Anne (VerfasserIn) , Scherl, Claudia (VerfasserIn) , Rotter, Nicole (VerfasserIn) , Affolter, Annette (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: September 2024
In: Journal of immunotherapy
Year: 2024, Jahrgang: 47, Heft: 7, Pages: 258-262
ISSN:1537-4513
DOI:10.1097/CJI.0000000000000513
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.1097/CJI.0000000000000513
Verlag, kostenfrei, Volltext: https://journals.lww.com/immunotherapy-journal/fulltext/2024/09000/nivolumab_as_a_promising_treatment_option_for.4.aspx
Volltext
Verfasserangaben:Luis Bugia, Frederic Jungbauer, Lena Zaubitzer, Christian Hörner, Kirsten Merx, Abo-Madyan Yasser, Thomas Germann, Anne Lammert, Claudia Scherl, Nicole Rotter, and Annette Affolter

MARC

LEADER 00000caa a2200000 c 4500
001 1908850078
003 DE-627
005 20241205220959.0
007 cr uuu---uuuuu
008 241118s2024 xx |||||o 00| ||eng c
024 7 |a 10.1097/CJI.0000000000000513  |2 doi 
035 |a (DE-627)1908850078 
035 |a (DE-599)KXP1908850078 
035 |a (OCoLC)1475647452 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Bugia, Luis  |d 1995-  |e VerfasserIn  |0 (DE-588)1348625880  |0 (DE-627)1908852127  |4 aut 
245 1 0 |a Nivolumab as a promising treatment option for metastatic salivary duct carcinoma  |c Luis Bugia, Frederic Jungbauer, Lena Zaubitzer, Christian Hörner, Kirsten Merx, Abo-Madyan Yasser, Thomas Germann, Anne Lammert, Claudia Scherl, Nicole Rotter, and Annette Affolter 
264 1 |c September 2024 
300 |b Illustrationen 
300 |a 5 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 18.11.2024 
520 |a Salivary duct carcinomas (SDC) of the parotid gland are rarely occurring highly malignant tumors. A 65-year-old man presented with a preauricular mass. After surgical treatment and histologic examination, the findings were interpreted as a squamous cell carcinoma (SCC) metastasis of the parotid gland deriving from a cancer of unknown primary DD primary SCC of the parotid gland. Adjuvant platinum-based radiochemotherapy was administered in domo. However, re-staging revealed multiple size-progressive pulmonary round lesions. After resection and histological examination of a pulmonary mass and in synopsis with the primary tumor, the initial diagnosis of SCC was revised to SDC of the parotid gland. With positive HER-2 status, off-label trastuzumab/docetaxel was initiated in an individual healing attempt, during which the pulmonary metastases showed clear progression. Consequently, the patient received immunotherapy with nivolumab according to his negative PD-L1 status. After 57 cycles of nivolumab, the patient presents with partial remission and in good condition. We report, for the first time, a robust response of metastatic SDC to checkpoint inhibition with nivolumab without additional radiotherapy. 
700 1 |a Jungbauer, Frederic  |d 1992-  |e VerfasserIn  |0 (DE-588)1164403214  |0 (DE-627)1028853033  |0 (DE-576)508516803  |4 aut 
700 1 |a Zaubitzer, Lena  |d 1990-  |e VerfasserIn  |0 (DE-588)1201660882  |0 (DE-627)1685739520  |4 aut 
700 1 |a Hörner, Christian  |d 1974-  |e VerfasserIn  |0 (DE-588)128891130  |0 (DE-627)384629237  |0 (DE-576)297385747  |4 aut 
700 1 |a Merx, Kirsten  |d 1970-  |e VerfasserIn  |0 (DE-588)122413091  |0 (DE-627)70589892X  |0 (DE-576)293258910  |4 aut 
700 1 |a Yasser, Abo-Madyan  |e VerfasserIn  |4 aut 
700 1 |a Germann, Thomas  |d 1984-  |e VerfasserIn  |0 (DE-588)1083019414  |0 (DE-627)84783946X  |0 (DE-576)455617090  |4 aut 
700 1 |a Lammert, Anne  |d 1983-  |e VerfasserIn  |0 (DE-588)137533365  |0 (DE-627)695845284  |0 (DE-576)303406097  |4 aut 
700 1 |a Scherl, Claudia  |d 1977-  |e VerfasserIn  |0 (DE-588)132069555  |0 (DE-627)517465426  |0 (DE-576)298927101  |4 aut 
700 1 |a Rotter, Nicole  |d 1970-  |e VerfasserIn  |0 (DE-588)118085638  |0 (DE-627)079235514  |0 (DE-576)178653888  |4 aut 
700 1 |a Affolter, Annette  |d 1977-  |e VerfasserIn  |0 (DE-588)124918417  |0 (DE-627)368073726  |0 (DE-576)294568190  |4 aut 
773 0 8 |i Enthalten in  |t Journal of immunotherapy  |d Philadelphia, Pa. : Lippincott Williams & Wilkins, 1991  |g 47(2024), 7, Seite 258-262  |h Online-Ressource  |w (DE-627)330078151  |w (DE-600)2048797-6  |w (DE-576)100399150  |x 1537-4513  |7 nnas  |a Nivolumab as a promising treatment option for metastatic salivary duct carcinoma 
773 1 8 |g volume:47  |g year:2024  |g number:7  |g pages:258-262  |g extent:5  |a Nivolumab as a promising treatment option for metastatic salivary duct carcinoma 
856 4 0 |u https://doi.org/10.1097/CJI.0000000000000513  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u https://journals.lww.com/immunotherapy-journal/fulltext/2024/09000/nivolumab_as_a_promising_treatment_option_for.4.aspx  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20241118 
993 |a Article 
994 |a 2024 
998 |g 124918417  |a Affolter, Annette  |m 124918417:Affolter, Annette  |d 60000  |d 62100  |d 60000  |e 60000PA124918417  |e 62100PA124918417  |e 60000PA124918417  |k 0/60000/  |k 1/60000/62100/  |k 0/60000/  |p 11  |y j 
998 |g 118085638  |a Rotter, Nicole  |m 118085638:Rotter, Nicole  |d 60000  |d 62100  |e 60000PR118085638  |e 62100PR118085638  |k 0/60000/  |k 1/60000/62100/  |p 10 
998 |g 132069555  |a Scherl, Claudia  |m 132069555:Scherl, Claudia  |d 60000  |d 62100  |e 60000PS132069555  |e 62100PS132069555  |k 0/60000/  |k 1/60000/62100/  |p 9 
998 |g 137533365  |a Lammert, Anne  |m 137533365:Lammert, Anne  |d 60000  |d 62100  |e 60000PL137533365  |e 62100PL137533365  |k 0/60000/  |k 1/60000/62100/  |p 8 
998 |g 1083019414  |a Germann, Thomas  |m 1083019414:Germann, Thomas  |d 50000  |e 50000PG1083019414  |k 0/50000/  |p 7 
998 |g 122413091  |a Merx, Kirsten  |m 122413091:Merx, Kirsten  |d 60000  |e 60000PM122413091  |k 0/60000/  |p 5 
998 |g 128891130  |a Hörner, Christian  |m 128891130:Hörner, Christian  |d 60000  |e 60000PH128891130  |k 0/60000/  |p 4 
998 |g 1201660882  |a Zaubitzer, Lena  |m 1201660882:Zaubitzer, Lena  |d 60000  |e 60000PZ1201660882  |k 0/60000/  |p 3 
998 |g 1164403214  |a Jungbauer, Frederic  |m 1164403214:Jungbauer, Frederic  |d 60000  |d 62100  |e 60000PJ1164403214  |e 62100PJ1164403214  |k 0/60000/  |k 1/60000/62100/  |p 2 
998 |g 1348625880  |a Bugia, Luis  |m 1348625880:Bugia, Luis  |d 60000  |e 60000PB1348625880  |k 0/60000/  |p 1  |x j 
999 |a KXP-PPN1908850078  |e 4615994710 
BIB |a Y 
SER |a journal 
JSO |a {"relHost":[{"origin":[{"publisher":"Lippincott Williams & Wilkins ; Ovid","dateIssuedKey":"1991","publisherPlace":"Philadelphia, Pa. ; [Erscheinungsort nicht ermittelbar]","dateIssuedDisp":"1991-"}],"disp":"Nivolumab as a promising treatment option for metastatic salivary duct carcinomaJournal of immunotherapy","type":{"media":"Online-Ressource","bibl":"periodical"},"recId":"330078151","id":{"issn":["1537-4513"],"zdb":["2048797-6"],"eki":["330078151"]},"language":["eng"],"note":["Gesehen am 24.11.20"],"pubHistory":["10.1991 -"],"part":{"text":"47(2024), 7, Seite 258-262","volume":"47","extent":"5","year":"2024","pages":"258-262","issue":"7"},"title":[{"title":"Journal of immunotherapy","title_sort":"Journal of immunotherapy","subtitle":"official journal of the Society for Biological Therapy"}],"physDesc":[{"extent":"Online-Ressource"}]}],"title":[{"title":"Nivolumab as a promising treatment option for metastatic salivary duct carcinoma","title_sort":"Nivolumab as a promising treatment option for metastatic salivary duct carcinoma"}],"physDesc":[{"extent":"5 S.","noteIll":"Illustrationen"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"recId":"1908850078","id":{"eki":["1908850078"],"doi":["10.1097/CJI.0000000000000513"]},"origin":[{"dateIssuedDisp":"September 2024","dateIssuedKey":"2024"}],"name":{"displayForm":["Luis Bugia, Frederic Jungbauer, Lena Zaubitzer, Christian Hörner, Kirsten Merx, Abo-Madyan Yasser, Thomas Germann, Anne Lammert, Claudia Scherl, Nicole Rotter, and Annette Affolter"]},"language":["eng"],"note":["Gesehen am 18.11.2024"],"person":[{"given":"Luis","role":"aut","family":"Bugia","display":"Bugia, Luis"},{"given":"Frederic","display":"Jungbauer, Frederic","role":"aut","family":"Jungbauer"},{"role":"aut","family":"Zaubitzer","display":"Zaubitzer, Lena","given":"Lena"},{"given":"Christian","family":"Hörner","role":"aut","display":"Hörner, Christian"},{"given":"Kirsten","display":"Merx, Kirsten","family":"Merx","role":"aut"},{"given":"Abo-Madyan","display":"Yasser, Abo-Madyan","role":"aut","family":"Yasser"},{"given":"Thomas","family":"Germann","role":"aut","display":"Germann, Thomas"},{"display":"Lammert, Anne","family":"Lammert","role":"aut","given":"Anne"},{"given":"Claudia","role":"aut","family":"Scherl","display":"Scherl, Claudia"},{"role":"aut","family":"Rotter","display":"Rotter, Nicole","given":"Nicole"},{"given":"Annette","display":"Affolter, Annette","role":"aut","family":"Affolter"}]} 
SRT |a BUGIALUISJNIVOLUMABA2024